Chemours Reports Strong 4th Quarter Results

The key measurement of EBITDA (earnings before interest, tax, depreciation and amortization) for Chemours fourth quarter was $239 million versus $132 million in the prior-year’s quarter.

1 Year Chemours Stock Performance. Screenshot from Google.
Other Highlights
  • Net Sales of $1.3 billion
  • Reduced costs by approximately $200 million in 2016 through transformation initiatives
  • Improved cash from operating activities by ~$412 million in 2016
  • Retired $385 million of long-term debt through December 31, 2016
See more at: https://investors.chemours.com/
Stay Up-to-Date on Business News in Wilmington.
Sign up for Our Weekly Newsletter!

[contact-form-7 id=”2651″ title=”Subscribe to WilmToday’s Weekly Newsletter”]

feature image: Wikimedia creative commons By Unknown – https://s2.q4cdn.com/107142371/files/doc_presentations/2015/Delisle-Site-Visit.pdf, Public Domain, https://commons.wikimedia.org/w/index.php?curid=45377629

 

 

Get in touch!

Share your email to receive monthly updates on all the best stuff in Wilmington! You know you wanna.